| Authors: |
Harris ED; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., McGovern M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Pernikoff S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ikeda R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kipnis L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Hannon W; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Sobolik EB; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Gray M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Greninger AL; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., He S; IgM Biosciences, Doylestown, PA, USA., Chin CN; IgM Biosciences, Doylestown, PA, USA., Fu TM; IgM Biosciences, Doylestown, PA, USA., Pancera M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. mpancera@fredhutch.org., Boonyaratanakornkit J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. jboonyar@fredhutch.org.; Department of Medicine, University of Washington, Seattle, WA, USA. jboonyar@fredhutch.org. |
